株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

Apceth GmbH & Co. KG の製品パイプライン分析

Apceth GmbH & Co. KG - Product Pipeline Review - 2015

発行 Global Markets Direct 商品コード 299296
出版日 ページ情報 英文 23 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.71円で換算しております。
Back to Top
Apceth GmbH & Co. KG の製品パイプライン分析 Apceth GmbH & Co. KG - Product Pipeline Review - 2015
出版日: 2015年04月15日 ページ情報: 英文 23 Pages
概要

Apceth GmbH & Co. KG はドイツに本社をおくバイオ製薬企業で、細胞治療薬の開発、製造、臨床試験の実施などに携わっています。製品には、末梢動脈閉塞性疾患治療薬や、臓器移植関連疾患、転移癌の治療薬などがあります。

レポートでは、Apceth GmbH & Co. KG における治療薬開発パイプラインの現況と各開発段階の比較分析、薬剤標的、作用機序、投与経路、分子タイプ別の治療薬の評価、最新の企業ニュースや発表、後期段階および中止されたプロジェクトに関する情報などを提供しています。

目次

Apceth GmbH & Co. KG の基本情報

  • Apceth GmbH & Co. KG の概要
  • 主要情報
  • 企業情報

Apceth GmbH & Co. KG :R&Dの概要

  • 主な治療範囲

Apceth GmbH & Co. KG :パイプラインのレビュー

  • 開発段階別のパイプライン製品
  • 単剤製品

Apceth GmbH & Co. KG :パイプライン製品の概況

  • 臨床段階のパイプライン製品
    • 第2相の製品/併用療法モダリティ
    • 第1相の製品/併用療法モダリティ
  • 初期段階のパイプライン製品
    • 前臨床段階の製品/併用療法モダリティ
    • 創薬段階の製品/併用療法モダリティ

Apceth GmbH & Co. KG :薬剤プロファイル

  • Agenmestencel-T
  • Alecmestencel-T
  • Alecmestencel-L

Apceth GmbH & Co. KG :パイプライン分析

  • 標的別
  • 投与経路別
  • 分子タイプ別
  • 作用機序別

Apceth GmbH & Co. KG :最新のパイプライン情報

Apceth GmbH & Co. KG :本社と子会社の所在地

  • 本社

付録

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GMDHC06946CDB

Summary

Global Markets Direct's, 'Apceth GmbH & Co. KG - Product Pipeline Review - 2015', provides an overview of the Apceth GmbH & Co. KG's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Apceth GmbH & Co. KG's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Apceth GmbH & Co. KG including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Apceth GmbH & Co. KG's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Apceth GmbH & Co. KG's pipeline products

Reasons to buy

  • Evaluate Apceth GmbH & Co. KG's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Apceth GmbH & Co. KG in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Apceth GmbH & Co. KG's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Apceth GmbH & Co. KG and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Apceth GmbH & Co. KG
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Apceth GmbH & Co. KG and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Apceth GmbH & Co. KG Snapshot
    • Apceth GmbH & Co. KG Overview
    • Key Information
    • Key Facts
  • Apceth GmbH & Co. KG - Research and Development Overview
    • Key Therapeutic Areas
  • Apceth GmbH & Co. KG - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Apceth GmbH & Co. KG - Pipeline Products Glance
    • Apceth GmbH & Co. KG - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • Apceth GmbH & Co. KG - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Apceth GmbH & Co. KG - Drug Profiles
    • Agenmestencel-T
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Alecmestencel-T
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Alecmestencel-L
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Apceth GmbH & Co. KG - Pipeline Analysis
    • Apceth GmbH & Co. KG - Pipeline Products by Target
    • Apceth GmbH & Co. KG - Pipeline Products by Route of Administration
    • Apceth GmbH & Co. KG - Pipeline Products by Molecule Type
    • Apceth GmbH & Co. KG - Pipeline Products by Mechanism of Action
  • Apceth GmbH & Co. KG - Recent Pipeline Updates
  • Apceth GmbH & Co. KG - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Apceth GmbH & Co. KG, Key Information
  • Apceth GmbH & Co. KG, Key Facts
  • Apceth GmbH & Co. KG - Pipeline by Indication, 2015
  • Apceth GmbH & Co. KG - Pipeline by Stage of Development, 2015
  • Apceth GmbH & Co. KG - Monotherapy Products in Pipeline, 2015
  • Apceth GmbH & Co. KG - Phase II, 2015
  • Apceth GmbH & Co. KG - Phase I, 2015
  • Apceth GmbH & Co. KG - Preclinical, 2015
  • Apceth GmbH & Co. KG - Discovery, 2015
  • Apceth GmbH & Co. KG - Pipeline by Target, 2015
  • Apceth GmbH & Co. KG - Pipeline by Route of Administration, 2015
  • Apceth GmbH & Co. KG - Pipeline by Molecule Type, 2015
  • Apceth GmbH & Co. KG - Pipeline Products by Mechanism of Action, 2015
  • Apceth GmbH & Co. KG - Recent Pipeline Updates, 2015
  • Apceth GmbH & Co. KG, Other Locations

List of Figures

  • Apceth GmbH & Co. KG - Pipeline by Top 10 Indication, 2015
  • Apceth GmbH & Co. KG - Pipeline by Stage of Development, 2015
  • Apceth GmbH & Co. KG - Monotherapy Products in Pipeline, 2015
  • Apceth GmbH & Co. KG - Pipeline by Top 10 Target, 2015
  • Apceth GmbH & Co. KG - Pipeline by Top 10 Route of Administration, 2015
  • Apceth GmbH & Co. KG - Pipeline by Top 10 Molecule Type, 2015
  • Apceth GmbH & Co. KG - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top